학술논문
Circulating Receptor Activator of Nuclear Factor kB Ligand and triglycerides are associated with progression of lower limb arterial calcification in type 2 diabetes: a prospective, observational cohort study
Document Type
article
Author
Olivier Bourron; Franck Phan; Mamadou Hassimiou Diallo; David Hajage; Carole-Elodie Aubert; Aurélie Carlier; Joe-Elie Salem; Christian Funck-Brentano; Salim Kemel; Philippe Cluzel; Alban Redheuil; Jean-Michel Davaine; Ziad Massy; Romuald Mentaverri; Dominique Bonnefont-Rousselot; Philippe Gillery; Stéphane Jaisson; Cees Vermeer; Jean-Marc Lacorte; Nesrine Bouziri; Suzanne Laroche; Chloé Amouyal; Agnes Hartemann
Source
Cardiovascular Diabetology, Vol 19, Iss 1, Pp 1-9 (2020)
Subject
Language
English
ISSN
1475-2840
Abstract
Abstract Background Lower limb arterial calcification is a frequent, underestimated but serious complication of diabetes. The DIACART study is a prospective cohort study designed to evaluate the determinants of the progression of lower limb arterial calcification in 198 patients with type 2 diabetes. Methods Lower limb arterial calcification scores were determined by computed tomography at baseline and after a mean follow up of 31.20 ± 3.86 months. Serum RANKL (Receptor Activator of Nuclear factor kB Ligand) and bone remodeling, inflammatory and metabolic parameters were measured at baseline. The predictive effect of these markers on calcification progression was analyzed by a multivariate linear regression model. Results At baseline, mean ± SD and median lower limb arterial calcification scores were, 2364 ± 5613 and 527 respectively and at the end of the study, 3739 ± 6886 and 1355 respectively. Using multivariate analysis, the progression of lower limb arterial log calcification score was found to be associated with (β coefficient [slope], 95% CI, p-value) baseline log(calcification score) (1.02, 1.00–1.04, p